These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19415450)

  • 1. Circulating immune complexes of Abeta and IgM in plasma of patients with Alzheimer's disease.
    Marcello A; Wirths O; Schneider-Axmann T; Degerman-Gunnarsson M; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2009 Jul; 116(7):913-20. PubMed ID: 19415450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease.
    Marcello A; Wirths O; Schneider-Axmann T; Degerman-Gunnarsson M; Lannfelt L; Bayer TA
    Neurobiol Aging; 2011 Aug; 32(8):1379-87. PubMed ID: 19781815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
    Xia W; Yang T; Shankar G; Smith IM; Shen Y; Walsh DM; Selkoe DJ
    Arch Neurol; 2009 Feb; 66(2):190-9. PubMed ID: 19204155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM response against amyloid-beta in aging: a potential peripheral protective mechanism.
    Agrawal S; Abud EM; Snigdha S; Agrawal A
    Alzheimers Res Ther; 2018 Aug; 10(1):81. PubMed ID: 30115117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood and Cerebrospinal Fluid Autoantibody to Aβ Levels in Patients with Alzheimer's Disease: a Meta-Analysis Study.
    Li XW; Li XX; Liu QS; Cheng Y
    J Mol Neurosci; 2020 Aug; 70(8):1208-1215. PubMed ID: 32212051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Plasma Based Biomarker of Alzheimer's Disease.
    Bradley-Whitman MA; Abner E; Lynn BC; Lovell MA
    J Alzheimers Dis; 2015; 47(3):761-71. PubMed ID: 26401710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-bound and free β-amyloid autoantibodies in serum of healthy adults.
    Maftei M; Thurm F; Leirer VM; von Arnim CA; Elbert T; Przybylski M; Kolassa IT; Manea M
    PLoS One; 2012; 7(9):e44516. PubMed ID: 22973459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis.
    Gustaw KA; Garrett MR; Lee HG; Castellani RJ; Zagorski MG; Prakasam A; Siedlak SL; Zhu X; Perry G; Petersen RB; Friedland RP; Smith MA
    J Neurochem; 2008 Aug; 106(3):1350-6. PubMed ID: 18485104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.
    Banks WA; Farr SA; Morley JE; Wolf KM; Geylis V; Steinitz M
    Exp Neurol; 2007 Aug; 206(2):248-56. PubMed ID: 17582399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of 4-hydroxynonenal adducts and responding autoantibodies correlate with the pathogenesis from hyperglycemia to Alzheimer's disease.
    Renuka Sanotra M; Huang WC; Silver S; Lin CY; Chang TC; Nguyen DPQ; Lee CK; Kao SH; Chang-Cheng Shieh J; Lin YF
    Clin Biochem; 2022 Mar; 101():26-34. PubMed ID: 34933007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls.
    Feinkohl I; Schipke CG; Kruppa J; Menne F; Winterer G; Pischon T; Peters O
    J Alzheimers Dis; 2020; 74(4):1285-1294. PubMed ID: 32176645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.
    Söllvander S; Ekholm-Pettersson F; Brundin RM; Westman G; Kilander L; Paulie S; Lannfelt L; Sehlin D
    J Alzheimers Dis; 2015; 48(1):63-72. PubMed ID: 26401929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
    Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S
    Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Aβ peptide promote Aβ oligomerization tendency of spiked synthetic Aβ in Alzheimer's disease plasma.
    Choi Y; Joh Y; Ryu JS; Kim K; Seo D; Kim S
    Mol Cell Neurosci; 2021 Mar; 111():103588. PubMed ID: 33422673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients.
    Maftei M; Thurm F; Schnack C; Tumani H; Otto M; Elbert T; Kolassa IT; Przybylski M; Manea M; von Arnim CA
    PLoS One; 2013; 8(7):e68996. PubMed ID: 23874844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects.
    Baril L; Nicolas L; Croisile B; Crozier P; Hessler C; Sassolas A; McCormick JB; Trannoy E
    Neurosci Lett; 2004 Jan; 355(3):226-30. PubMed ID: 14732472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
    Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
    J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
    Williams SM; Schulz P; Rosenberry TL; Caselli RJ; Sierks MR
    J Alzheimers Dis; 2017; 58(1):23-35. PubMed ID: 28372328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.